AFP and hepatocellular carcinoma: AFP is currently the most commonly used tumor marker for HCC, and according to the Asian HCC guidelines, the serum biomarker AFP is recommended as one of the monitoring and diagnostic tools for HCC (23, 24), however, many non-cancer sources involving liver and other organs may also lead to elevated AFP and thus have lower sensitivity and specificity (25).